Novartis AG NVS
$143.46
-0.20%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $153.00
- Implied Upside
- +6.6%
- Price Target Range
- $136.00 – $170.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-10 | HSBCRajesh Kumar |
Upgrades | Reduce → Hold | $123 → $136 |
| 2026-03-26 | Morgan StanleyMark Purcell |
Maintains | Overweight | $143 → $170 |
| 2026-01-06 | BarclaysEmmanuel Papada |
Upgrades | Underweight → Equal-weight | — |
| 2025-12-08 | JP MorganRichard Vosser |
Upgrades | Neutral → Overweight | — |
| 2025-10-27 | JefferiesMichael Leuchten |
Assumes | Hold | — |
| 2025-09-12 | Goldman SachsJames Quigley |
Downgrades | Neutral → Sell | $119 → $118 |
| 2025-02-13 | UBSMatthew Weston |
Downgrades | Buy → Neutral | — |
| 2024-11-19 | Erste GroupHans Engel |
Downgrades | Buy → Hold | — |
| 2024-10-30 | BMO CapitalEtzer Darout |
Maintains | Market perform | $118 → $120 |
| 2024-09-11 | B of A SecuritiesGraham Perry |
Downgrades | Buy → Neutral | $135 → $130 |
| 2024-09-05 | Goldman SachsJames Quigley |
Downgrades | Buy → Neutral | $119 → $121 |
| 2024-09-03 | JefferiesPeter Welford |
Downgrades | Buy → Hold | — |
| 2024-07-02 | JefferiesPeter Welford |
Maintains | Buy | $121 → $123 |
| 2024-04-24 | BMO CapitalEtzer Darout |
Maintains | Market perform | $114 → $116 |
| 2024-02-23 | BMO CapitalEtzer Darout |
Initiates coverage on | Market perform | $114 |
| 2024-01-23 | Morgan StanleyMark Purcell |
Initiates coverage on | Equal-weight | $114 |
| 2023-09-25 | Morgan StanleyVincent Meunier |
Upgrades | Underweight → Equal-weight | — |
| 2022-05-09 | Wolfe ResearchTim Anderson |
Downgrades | Outperform → Peer perform | — |
| 2021-12-06 | Exane BNP ParibasRichard Parkes |
Downgrades | Outperform → Neutral | — |
| 2021-12-03 | Bryan GarnierJeanjacques Le Fur |
Downgrades | Buy → Neutral | — |
| 2021-09-20 | Deutsche BankEmmanuel Papadakis |
Downgrades | Hold → Sell | — |
| 2021-03-10 | Argus ResearchDavid Toung |
Downgrades | Buy → Hold | — |
| 2021-02-01 | Cowen & Co.Steve Scala |
Downgrades | Outperform → Market perform | $110 → $105 |
| 2021-01-15 | Deutsche BankEmmanuel Papadakis |
Initiates coverage on | Buy | — |
| 2020-09-01 | Morgan StanleyVincent Meunier |
Upgrades | Equal-weight → Overweight | — |
| 2020-02-25 | GuggenheimSeamus Fernandez |
Downgrades | Buy → Neutral | — |
| 2019-04-25 | GuggenheimSeamus Fernandez |
Upgrades | Neutral → Buy | — |
| 2019-04-10 | Morgan StanleyVincent Meunier |
Downgrades | Equal-weight → Underweight | — |
| 2018-12-11 | Jefferies |
Assumes | Buy | $105 |
| 2018-11-26 | Cowen & Co.Steve Scala |
Upgrades | Market perform → Outperform | $100 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $143.46
- Market Cap
- $273.23 billion
- 52-Week Range
- $121.57 – $170.46
- Average Volume
- 2.36 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.